In a review of 32 mixed-type human studies, multinational researchers found a growing association between various classes of ...

Crohn’s disease and ulcerative colitis, which are the most common types of inflammatory bowel disease (IBD), are more common ...

Quarterly tracking of market dynamics in rapidly evolving areas like IgA nephropathy, atopic dermatitis, generalized myasthenia gravis (gMG), systemic lupus erythematosus (SLE), and inflammatory bowel ...

Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the ...

The study reveals that moderate fever enhances CD4 T cell activity while reducing regulatory T cell suppression, highlighting ...

CureLab Veterinary Inc, a biopharmaceutical company that develops cancer treatments for pets, announced a Regulation D ...

Learn about colorectal cancer, its risk factors, symptoms, and the latest treatment options. Early detection through ...

Responder analyses demonstrated that approximately nine out of 10 patients treated with BIMZELX who achieved PASI90 at Year 1, and over seven out of 10 patients who achieved complete skin clearance ...

Fintel reports that on September 24, 2024, TD Cowen initiated coverage of Protagonist Therapeutics (NasdaqGM:PTGX) with a Buy ...

Fzata, Inc. is pleased to announce a five-year UG3/UH3 non-dilutive grant (UG3NS135350) of up to $7 million, plus in-kind ...

Breakdown of the mucus barrier, which separates the intestinal epithelium from the microbiota, is a hallmark of inflammatory ...